Streetbeat News

Regulatory

AAPL

FXI

SPY

The China Commerce Ministry has discussed Apple's development in China and the U.S-China trade relationship, according to Reuters. The specific details of the discussion were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:59 pm

META

Instagram's Threads app, owned by Meta Platforms Inc (NASDAQ:META), temporarily blocked users from searching health-related terms, including those associated with COVID-19. The block is part of Threads' efforts to foster a positive culture and prevent misinformation. The company plans to lift the block in the coming weeks or months. This decision has faced criticism for limiting access to vital information.

Portfolio Pulse from Anusuya Lahiri

October 18, 2023 | 12:57 pm

F

GM

HMC

STLA

TM

TSLA

Tesla has urged the National Highway Traffic Safety Administration to focus on energy conservation and environmental impacts of fossil fuel use. The company wants to eliminate off-cycle credits from 2027 and suggests a stringent Corporate Average Fuel Economy proposal requiring carmakers to achieve an average of nearly 75 miles per gallon by 2032. The Alliance for Automotive Innovation, representing automakers including Ford, General Motors, Stellantis, Honda, and Toyota, has said that the NHTSA's proposal would result in manufacturers facing fines amounting to $14 billion.

Portfolio Pulse from Nabaparna Bhattacharya

October 18, 2023 | 12:52 pm

ARDX

FND

UAL

Ardelyx (ARDX) shares surged 24.5% after FDA approval of XPHOZAH, a first-in-class phosphate absorption inhibitor. United Airlines (UAL) shares dropped 7% following Q3 results and guidance, warning that Q4 EPS could be as low as $1.50 if Tel Aviv flight suspensions continue. Floor & Decor (FND) shares rose 9% after announcing the grand opening of a store in Hyannis, Massachusetts.

Portfolio Pulse from ryanfaloona@benzinga.com

October 18, 2023 | 12:43 pm

EVOK

Evoke Pharma, Inc. (NASDAQ:EVOK) announced that its healthcare utilization data suggesting reduced healthcare costs for patients on GIMOTI nasal spray versus oral metoclopramide will be presented at the American College of Gastroenterology annual meeting. The data builds upon previous findings demonstrating significant reductions in healthcare resource utilization. The study shows that nasal treatment of diabetic gastroparesis patients not only significantly reduces the number of ER visits and hospitalizations, but also the costs of treatment.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:36 pm

WKHS

Workhorse Group Inc. has entered the FAA process to put the WA4-100 on UPS Flight Forward's FAA Part 135 'Drone Airline' Certificate. This move is a significant step towards the commercialization of drone delivery services.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:36 pm

CKPT

Checkpoint Therapeutics has announced the publication of results from a pivotal trial of cosibelimab, a potential best-in-class anti-PD-L1 antibody, in patients with metastatic cutaneous squamous cell carcinoma. The study found cosibelimab to have a robust and clinically meaningful objective response rate, with durable responses and a well-tolerated safety profile. The company is working with the FDA towards a January 3, 2024, action date for their Biologics License Application for cosibelimab.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:35 pm

DATS

DatChat (NASDAQ:DATS), a secure messaging, social media, and metaverse company, has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application titled 'Technology platform for providing secure group-based access to sets of digital assets.' The patent will protect the core technology that will power DatChat's secure personal and enterprise data archive platform, expected to launch in early 2024.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:34 pm

ICU

SeaStar Medical Holding Corporation (NASDAQ:ICU) has received the U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for its Selective Cytopheretic Device (SCD) for use with patients with acute kidney injury and acute on chronic liver failure. This is the third such designation granted to SeaStar for the SCD device, which is expected to expedite its clinical development and regulatory review. The SCD has shown potential in improving solid organ function in various conditions, including sepsis, AKI, cardiorenal syndrome, and COVID-19.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:33 pm

GENE

Genetic Technologies Limited (NASDAQ:GENE) has announced the publication of a peer-reviewed research paper validating geneType's Pancreatic Cancer risk assessment test. The test showed a nearly 50% improvement to the traditional clinical risk score in identifying patients at a high risk of developing pancreatic cancer. The study evaluated close to 380,000 adults aged 40 to 69 years from the UK Biobank.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:33 pm